615 Dupilumab Elicits Rapid and Sustained Improvements in Itch in Adults With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.691
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Dupilumab Versus Cyclosporine for Treatment of Moderate-To-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index

Acta Dermato-Venereologica
DermatologyMedicine
2019English

Pss43 - Dupilumab Improves Absenteeism in Moderate-To-Severe Atopic Dermatitis Patients Compared With Placebo in Phase 3 Liberty Ad Solo Studies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Peak Pruritus Numerical Rating Scale: Psychometric Validation and Responder Definition for Assessing Itch in Moderate‐To‐Severe Atopic Dermatitis

British Journal of Dermatology
DermatologyMedicine
2019English

673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

After the Approval of Dupilumab for Moderate-To-Severe Atopic Dermatitis: What Is Next on the Research Agenda?

British Journal of Dermatology
DermatologyMedicine
2018English

Dupilumab Treatment Improves Quality of Life in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results From a Randomized, Placebo-Controlled Clinical Trial

British Journal of Dermatology
DermatologyMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy